Fresenius Medical Care | FME - Operating Expenses



Fresenius Medical Care reported EUR4.36B in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Akzo Nobel EUR 2.32B 98M Jun/2025
Alcon AG USD 2.35B 344M Jun/2025
AstraZeneca USD 10.95B 1.04B Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Beiersdorf EUR 4.37B 143M Jun/2025
DaVita Healthcare Partners USD 2.85B 58.85M Jun/2025
Demant DKK 9.39B 392M Jun/2025
E.ON EUR 15.28B 8.5B Jun/2025
Essilor EUR 12.02B 308M Jun/2025
Fresenius EUR 5.02B 57M Jun/2025
Fresenius Medical Care EUR 4.36B 189M Jun/2025
Genmab DKK 565M 38M Jun/2025
Getinge SEK 9.99B 2.3B Dec/2024
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 5.96B 663M Jun/2025
GN Store Nord DKK 3.7B 72M Jun/2025
GRIFOLS EUR 1.54B 24.64M Jun/2025
Hikma Pharmaceutical USD 1.31B 63M Dec/2024
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.22B 49M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Philips EUR 3.85B 93M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
RWE EUR 3.04B 2.6B Jun/2025
Sanofi EUR 9.02B 702M Jun/2025
SAP EUR 6.57B 109M Jun/2025
Smith & Nephew USD 2.52B 133M Jun/2025